Cabaletta Bio Inc. (CABA) NASDAQ
$12.61 (0.08) (-0.63%)
Market Cap: $593.95M
As of 05/16/24 02:19 PM EDT. Market open.
Cabaletta Bio Inc. (CABA)
NASDAQ
$12.61
(0.08) (-0.63%)
Market Cap: $593.95M
As of 05/16/24 02:19 PM EDT. Market open.
Add to Portfolio
cabaletta bio, inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered t cell therapies for patients with b cell-mediated autoimmune diseases. its proprietary technology utilizes chimeric autoantibody receptor (caar) t cells that are designed to selectively bind and eliminate b cells, which produce disease-causing autoantibodies or pathogenic b cells. ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
66
Address
.
PRICE CHART FOR CABALETTA BIO INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$12.55
Previous Close
$12.69
Days Range
$11.79 - $13.12
52 week range
$9.02 - $26.35
Volume
291,865
Avg. Volume (30 days)
1,455,963
Market Cap
$593.95M
Dividend Yield
-
P/E
-
Shares Outstanding
46,804,820
Open
$12.55
Previous Close
$12.69
Days Range
$11.79 - $13.12
52 week range
$9.02 - $26.35
Volume
291,865
Avg. Volume (30 days)
1,455,963
Market Cap
$593.95M
Dividend Yield
-
P/E
-
Shares Outstanding
46,804,820
FINANCIAL STATEMENTS FOR CABALETTA BIO INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CABALETTA BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Binder Gwendolyn | See Remarks | Jan 19, 2024 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Jan 19, 2024, 06:30 PM |
| Binder Gwendolyn | See Remarks | Jan 19, 2024 | Sale | $19.59 | 11,000 | 215,439 | 20,700 | Jan 19, 2024, 06:30 PM |
| Binder Gwendolyn | See Remarks | Dec 19, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Dec 19, 2023, 08:37 PM |
| Binder Gwendolyn | See Remarks | Dec 19, 2023 | Sale | $21.89 | 11,000 | 240,789 | 23,132 | Dec 19, 2023, 08:37 PM |
| Binder Gwendolyn | See Remarks | Nov 20, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Nov 21, 2023, 04:30 PM |
| Binder Gwendolyn | See Remarks | Nov 20, 2023 | Sale | $17.82 | 11,000 | 196,014 | 27,458 | Nov 21, 2023, 04:30 PM |
| Binder Gwendolyn | See Remarks | Oct 19, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Oct 19, 2023, 07:40 PM |
| Binder Gwendolyn | See Remarks | Oct 19, 2023 | Sale | $13.36 | 11,000 | 146,921 | 20,408 | Oct 19, 2023, 07:40 PM |
| Binder Gwendolyn | See Remarks | Sep 19, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Sep 20, 2023, 04:30 PM |
| Binder Gwendolyn | See Remarks | Sep 19, 2023 | Sale | $17.57 | 11,000 | 193,220 | 20,700 | Sep 20, 2023, 04:30 PM |
| Binder Gwendolyn | See Remarks | Aug 21, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Aug 22, 2023, 04:30 PM |
| Binder Gwendolyn | See Remarks | Aug 21, 2023 | Sale | $13.42 | 11,000 | 147,583 | 20,300 | Aug 22, 2023, 04:30 PM |
| Binder Gwendolyn | See Remarks | Jul 19, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Jul 19, 2023, 08:37 PM |
| Binder Gwendolyn | See Remarks | Jul 19, 2023 | Sale | $13.82 | 11,000 | 152,022 | 22,815 | Jul 19, 2023, 08:37 PM |
| Binder Gwendolyn | See Remarks | Jun 20, 2023 | Option Exercise | $1.01 | 11,000 | 11,110 | 31,000 | Jun 21, 2023, 04:38 PM |
| Binder Gwendolyn | See Remarks | Jun 20, 2023 | Sale | $12.99 | 11,000 | 142,925 | 20,000 | Jun 21, 2023, 04:38 PM |
| Binder Gwendolyn | See Remarks | May 19, 2023 | Option Exercise | $1.01 | 22,000 | 22,220 | 42,000 | May 19, 2023, 08:10 PM |
| Binder Gwendolyn | See Remarks | May 19, 2023 | Sale | $11.81 | 22,000 | 259,833 | 20,000 | May 19, 2023, 08:10 PM |
| Nichtberger Steven | President & CEO | Oct 19, 2022 | Buy | $1.25 | 8,127 | 10,152 | 986,483 | Oct 19, 2022, 08:19 PM |
| Bollard Catherine | Director | Oct 18, 2022 | Buy | $0.99 | 1,000 | 993 | 1,000 | Oct 18, 2022, 09:51 PM |
| Marda Anup | Chief Financial Officer | Oct 18, 2022 | Buy | $0.99 | 50,000 | 49,620 | 50,000 | Oct 18, 2022, 09:50 PM |
| Simon Mark | Director | Oct 18, 2022 | Buy | $0.98 | 118,000 | 115,286 | 136,144 | Oct 18, 2022, 09:50 PM |
| Simon Mark | Director | Oct 18, 2022 | Buy | $0.98 | 7,000 | 6,835 | 7,000 | Oct 18, 2022, 09:50 PM |
| Binder Gwendolyn | See Remarks | Oct 18, 2022 | Buy | $0.99 | 20,000 | 19,894 | 20,000 | Oct 18, 2022, 09:50 PM |
| Nichtberger Steven | President & CEO | Oct 18, 2022 | Buy | $0.99 | 141,873 | 141,008 | 978,356 | Oct 18, 2022, 09:50 PM |
| Nichtberger Steven | President & CEO | Jan 31, 2022 | Option Exercise | $1.01 | 50,000 | 50,500 | 836,483 | Feb 02, 2022, 04:26 PM |
| 5AM Ventures V, L.P. | 10% Owner | Nov 01, 2021 | Sale | $13.00 | 295,000 | 3,835,000 | 1,731,119 | Nov 03, 2021, 04:38 PM |
| 5AM Ventures V, L.P. | 10% Owner | Sep 07, 2021 | Sale | $9.70 | 625,000 | 6,062,500 | 1,989,575 | Sep 09, 2021, 05:34 PM |
| 5AM Ventures V, L.P. | 10% Owner | Jan 12, 2021 | Sale | $13.00 | 85,000 | 1,105,000 | 2,614,575 | Jan 12, 2021, 05:07 PM |
| 5AM Ventures V, L.P. | 10% Owner | Jan 08, 2021 | Sale | $13.00 | 302,000 | 3,926,000 | 2,689,045 | Jan 12, 2021, 05:07 PM |
| 5AM Ventures V, L.P. | 10% Owner | Dec 10, 2020 | Sale | $14.75 | 298,000 | 4,395,500 | 2,953,634 | Dec 14, 2020, 05:58 PM |
| 5AM Ventures V, L.P. | 10% Owner | Oct 29, 2019 | Buy | $11.00 | 454,545 | 4,999,995 | 454,545 | Oct 31, 2019, 06:03 PM |
| Flynn James E | 10% Owner | Oct 29, 2019 | Buy | $11.00 | 700,000 | 7,700,000 | 700,000 | Oct 30, 2019, 06:04 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN CABALETTA BIO INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 4,057,113 | 0.00161% | -7.98% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,036,645 | 0.1% | -7.04% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,258,650 | 0.37% | -37.31% | Other |
| HOLOCENE ADVISORS, LP | 1,920,323 | 0.17% | Exited | Growth At A Reasonable Price |
| GEODE CAPITAL MANAGEMENT, LLC | 773,090 | 0.00122% | 2.64% | Other |
| DUQUESNE FAMILY OFFICE LLC | 417,000 | 0.16% | New | Other |
| BLACKSTONE INC. | 46,780 | 0.00322% | -86.54% | Other |
| CANDRIAM S.C.A. | 200,000 | 0.02% | New | Other |
| RENAISSANCE TECHNOLOGIES LLC | 59,000 | 0.00158% | New | Other |
| TUDOR INVESTMENT CORP ET AL | 21,314 | 0.00231% | New | Event Driven, Other |
| D. E. SHAW & CO., INC. | 16,111 | 0.00024% | New | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 14,963 | 0.00045% | New | Event Driven |
| AQR CAPITAL MANAGEMENT LLC | 12,311 | 0.00036% | -10.54% | Other |
| BAKER BROS. ADVISORS LP | 13,331 | 0.00285% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR CABALETTA BIO INC
STOCK BUYBACKS FOR CABALETTA BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
7.65%
1Q
03/31/2023
36.72%
3Q
12/31/2022
47.69%
4Q
09/30/2022
47.69%
5Q
06/30/2022
47.87%
6Q
03/31/2022
47.87%
7Q
12/31/2021
51.24%
8Q
09/30/2021
71.58%
9Q
06/30/2021
71.89%
10Q
03/31/2021
78.07%
11Q
12/31/2020
78.13%
12Q
09/30/2020
78.25%
13Q
06/30/2020
78.29%
14Q
03/31/2020
78.29%
15Q
12/31/2019
78.29%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CABALETTA BIO INC
LOADING...